Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To Sleep System™ in improving the sleep quality of children with Autism Spectrum Disorder (ASD). The Sound To Sleep System™ is a mattress foundation designed to improve sleep quality in individuals with ASD and sleep disturbance by providing mattress vibrations that accompany and sync with auditory stimulation. For the present study, the primary objectives are as follows: \* Study Aim 1 - To determine whether the use of the Sound To Sleep System™ in ASD-affected children with sleep disturbances is well tolerated as defined by group drop-out proportion due to issues with the mattress technology. The study will also explore the following objectives:
- Study Aim 2 - To determine the efficacy of the Sound To Sleep System™ in improving sleep quality as measured by parent reported sleep quality in ASD-affected children with sleep disturbances. (Please note Study Aim 2 was changed from clinician-rated to parent-rated because we were not able to collect clinician-rated sleep quality information).
- Study Aim 3 - To determine the tolerability of the Sound To Sleep System™ as defined by study drop-out due to any reason and caregiver ratings of ease of mattress technology use.
- Study Aim 4 - To determine whether use of the mattress technology improves functioning as defined by secondary outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedFirst Posted
Study publicly available on registry
April 15, 2016
CompletedResults Posted
Study results publicly available
November 6, 2017
CompletedNovember 6, 2017
October 1, 2017
1.6 years
July 21, 2014
February 13, 2017
October 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare Percentage of Participants Who Drop Out of Study as a Measure of Toleration of Mattress Technology
Compare percentage of drop-out, in this cohort, due to issues with the mattress technology (e.g. ease of use, inability to fall asleep) to a population expected drop-out rate of 30% using a one-sample proportion test.
up to 6 weeks
Secondary Outcomes (17)
Parent Reported Quality of Sleep Across Treatment Conditions
Average daily score, across up to 2 weeks
Total Time Asleep Recorded by Actigraphy Watch
Average of daily measure, across up to 2 weeks
Total Time to Fall Asleep (Sleep Latency) Recorded by Actigraphy Watch
Average of daily measure, across up to 2 weeks
Total Time Awake During Night Recorded by Actigraphy Watch
Average of daily measure, across up to 2 weeks
Percentage of Time in Bed That the Participant Spent Sleeping (Sleep Efficiency) Recorded by Actigraphy Watch.
Average of daily measure, across up to 2 weeks
- +12 more secondary outcomes
Study Arms (2)
Mattress Technology On then Off
EXPERIMENTALIntervention: Sound to Sleep System will be turned on for the first two weeks of the study allowing the participant sleeping atop the mattress to feel the vibrations synced to the audio input. Sound to sleep system will be turned on during this phase of the study. The sound to sleep system will sync an audio input with the vibrations of the mattress technology and allow the user to control the intensity of the vibration. No intervention: The mattress technology will be turned off for the second two weeks of the study. During this time, there will be no intervention.
Mattress Technology Turned Off then On
EXPERIMENTALNo intervention: For the first two weeks of the study, the mattress technology will not be turned off. There will be no intervention during this time. Intervention: Sound to Sleep System will be turned on for the second two weeks of the study allowing the participant sleeping atop the mattress to feel the vibrations synced to the audio input. Sound to sleep system will be turned on during this phase of the study. The sound to sleep system will sync an audio input with the vibrations of the mattress technology and allow the user to control the intensity of the vibration.
Interventions
Sound to Sleep System is a minimal risk device that is embedded in a mattress boxspring. The device syncs with an audio input and emits tactile vibrations in sync with the audio input.
Eligibility Criteria
You may qualify if:
- ASD Diagnosis
- Years of Age
- Sleep Difficulty as indicated by significant sleep disturbance on the Child Sleep Habits Questionnaire
- If participant is using medication or attends therapy, it must be stable four (4) weeks prior to their study participation and throughout the 5-6 week study period.
You may not qualify if:
- Age less than 2.5 years or more than 12.99 years
- Individuals who may have medication or therapy changes 4 weeks prior to study start date or during the study period
- An participant diagnosed with epilepsy, Fragile X, Downs Syndrome, seizure disorder, Neurofibromatosis, or Tuberous Sclerosis
- Any child with a pacemaker or other electrical device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Cleveland Cliniclead
- Kugona LLCcollaborator
Study Sites (1)
Cleveland Clinic Center for Autism
Cleveland, Ohio, 44104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Thomas Frazier
- Organization
- The Cleveland Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Frazier, PhD
The Cleveland Clinic
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Thomas W. Frazier, Ph.D
Study Record Dates
First Submitted
July 21, 2014
First Posted
April 15, 2016
Study Start
May 1, 2014
Primary Completion
December 1, 2015
Study Completion
February 1, 2016
Last Updated
November 6, 2017
Results First Posted
November 6, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share